Trial · NCT01913639
Adverse events94
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
61 to 80 of 94
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Constipation | Gastrointestinal disorders | FOLFOX Plus Regorafenib | 5 | 39 | |
| serious | Cough | Respiratory, thoracic and mediastinal disorders | FOLFOX Plus Regorafenib | 1 | 39 | |
| serious | Death NOS | General disorders | FOLFOX Plus Regorafenib | 1 | 39 | |
| serious | Dehydration | Metabolism and nutrition disorders | FOLFOX Plus Regorafenib | 2 | 39 | |
| serious | Diarrhea | Gastrointestinal disorders | FOLFOX Plus Regorafenib | 1 | 39 | |
| serious | Dyspnea | Respiratory, thoracic and mediastinal disorders | FOLFOX Plus Regorafenib | 4 | 39 | |
| serious | Fatigue | General disorders | FOLFOX Plus Regorafenib | 3 | 39 | |
| serious | Febrile neutropenia | Blood and lymphatic system disorders | FOLFOX Plus Regorafenib | 1 | 39 | |
| serious | Fever | General disorders | FOLFOX Plus Regorafenib | 4 | 39 | |
| serious | Gastrointestinal disorders -Other, specify | Gastrointestinal disorders | FOLFOX Plus Regorafenib | 2 | 39 | |
| serious | Hypertension | Vascular disorders | FOLFOX Plus Regorafenib | 1 | 39 | |
| serious | Hypotension | Vascular disorders | FOLFOX Plus Regorafenib | 2 | 39 | |
| serious | Left ventricular systolic dysfunction | Cardiac disorders | FOLFOX Plus Regorafenib | 1 | 39 | |
| serious | Lipase increased | Investigations | FOLFOX Plus Regorafenib | 1 | 39 | |
| serious | Muscle weakness left-sided | Nervous system disorders | FOLFOX Plus Regorafenib | 1 | 39 | |
| serious | Nausea | Gastrointestinal disorders | FOLFOX Plus Regorafenib | 3 | 39 | |
| serious | Neutrophil count decreased | Investigations | FOLFOX Plus Regorafenib | 2 | 39 | |
| serious | Non-cardiac chest pain | General disorders | FOLFOX Plus Regorafenib | 1 | 39 | |
| serious | Pain | General disorders | FOLFOX Plus Regorafenib | 1 | 39 | |
| serious | Paresthesia | Nervous system disorders | FOLFOX Plus Regorafenib | 1 | 39 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01913639/events?page=4